Asian Cohort for Alzheimer's Disease (ACAD) pilot study on genetic and non‐genetic risk factors for Alzheimer's disease among Asian Americans and Canadians
Aging
Canada
Biological Psychology
Clinical Sciences
Clinical Trials and Supportive Activities
610
Clinical sciences
Pilot Projects
Neurodegenerative
Alzheimer's Disease
environmental
Environmental
03 medical and health sciences
0302 clinical medicine
Clinical Research
Alzheimer Disease
Risk Factors
Genetics
Acquired Cognitive Impairment
Psychology
Humans
Minority Health
genetics
Research Articles
community-based participatory research
Community-based participatory research
Biomedical and Clinical Sciences
Asian
North American People
Prevention
Neurosciences
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Alzheimer's disease
Biosamples
Brain Disorders
Health Disparities
Geriatrics
Neurological
Biological psychology
Dementia
biosamples
2.4 Surveillance and distribution
dementia
DOI:
10.1002/alz.13611
Publication Date:
2024-01-12T18:15:01Z
AUTHORS (82)
ABSTRACT
AbstractINTRODUCTIONClinical research in Alzheimer's disease (AD) lacks cohort diversity despite being a global health crisis. The Asian Cohort for Alzheimer's Disease (ACAD) was formed to address underrepresentation of Asians in research, and limited understanding of how genetics and non‐genetic/lifestyle factors impact this multi‐ethnic population.METHODSThe ACAD started fully recruiting in October 2021 with one central coordination site, eight recruitment sites, and two analysis sites. We developed a comprehensive study protocol for outreach and recruitment, an extensive data collection packet, and a centralized data management system, in English, Chinese, Korean, and Vietnamese.RESULTSACAD has recruited 606 participants with an additional 900 expressing interest in enrollment since program inception.DISCUSSIONACAD's traction indicates the feasibility of recruiting Asians for clinical research to enhance understanding of AD risk factors. ACAD will recruit > 5000 participants to identify genetic and non‐genetic/lifestyle AD risk factors, establish blood biomarker levels for AD diagnosis, and facilitate clinical trial readiness.HIGHLIGHTS
The Asian Cohort for Alzheimer's Disease (ACAD) promotes awareness of under‐investment in clinical research for Asians.
We are recruiting Asian Americans and Canadians for novel insights into Alzheimer's disease.
We describe culturally appropriate recruitment strategies and data collection protocol.
ACAD addresses challenges of recruitment from heterogeneous Asian subcommunities.
We aim to implement a successful recruitment program that enrolls across three Asian subcommunities.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (63)
CITATIONS (7)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....